報價延遲最少15分鐘:2025/01/21 18:57 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
25.12 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.09/2.49
|
|
企業價值
3.51B
|
| 資產負債 |
|
每股賬面淨值
19.72
|
| 現金流量 |
|
現金流量率
0.07
|
| 損益表 |
|
收益
1.54B
|
|
每股收益
19.99
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 18:57 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |